Martin Rudwaleit
28PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (28)
Sort by Publication Date:
|Dec 19, 2025
Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials.John D Reveille, Martin Rudwaleit, Proton Rahman
|Nov 28, 2025
Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies.Helena Marzo-Ortega, Victoria Navarro-Compan, Maureen Dubreuil
|Sep 24, 2025
Longitudinal association of early axial spondyloarthritis status at the time of diagnosis with disease activity over time: 10-year results from the GESPIC cohort.David Kiefer, Imke Redeker, Murat Torgutalp
|Apr 09, 2025
BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis.Martin Rudwaleit, Victoria Navarro-Compán, Hagen Russ
|Oct 15, 2024
Improved Pain, Morning Stiffness, and Fatigue With Bimekizumab in Axial Spondyloarthritis: Results From the Phase III BE MOBILE Studies.Victoria Navarro-Compán, Martin Rudwaleit, Maureen Dubreuil
Pageof 5
Frequent Collaborators
13 joint publications
Victoria Navarro-Compán
10 joint publications
Xenofon Baraliakos
10 joint publications
Denis Poddubnyy
7 joint publications
Helena Marzo-Ortega
7 joint publications
Pedro Machado
7 joint publications
Désirée van der Heijde
6 joint publications
Joachim Sieper
5 joint publications
Ulrich Weber
5 joint publications
Manouk de Hooge
5 joint publications
Robert Landewé